Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-083-8 | CAS number: 68002-70-0 This substance is identified by SDA Substance Name: C16-C22 trialkyl glyceride and SDA Reporting Number: 21-001-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral NOAEL for risk assessment purposes: 7.5% in feed, equivalent to an estimated 3,750 mg/kg bw/day.
Dermal exposure is lower than oral due to lower penetration (10 versus up to 17%).
No significant respiratory exposure.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 3 750 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
Justification for classification or non-classification
A large number of repeated dose oral toxicity studies have been conducted with ‘glycerides, C16-22 (SDA Reporting Number: 21-001-00)’ and other substances of the same read-across category. These studies are usually conducted in the form of various vegetable oils at different degrees of hydrogenation, particularly in the context of nutritional research as well as in toxicological investigations. As defined in the present Chemical Safety Report (see Section 1.2), ‘glycerides, C16-22 (SDA Reporting Number: 21-001-00)’ is a component of normal diets.Differences may be observed on bodyweight gain, food consumption and certain measured parameters depending on the nature, chain length distribution of the fatty acids associated to the glycerides and their degree of unsaturation. Similar results were obtained for the other substances of the same read-across category. But overall research indicates that, when consumed at nutritionally relevant concentrations (i.e. typically up to the equivalent of 35% of calories in food), there are no adverse effects on health and longevity. The maximum levels of erucic acid in food, are limited in Europe to10% in oil for human consumption and 5% as total level of fatty acids in the fat component of diets.
Across all studies, tested doses ranged from 7.5 to 19% in diet. No significant toxicity was seen at any of the tested dose rates. For risk assessment purposes, the relevant oral NOAEL could therefore conservatively be considered to be 7.5% in diet (the NOAEL for ‘glycerides, C16-22 (SDA Reporting Number: 21-001-00)’), on the basis of a sub-chronic feeding study, which is equivalent to an estimated 3,750 mg/kg bw/day.
‘Glycerides, C16-22 (SDA Reporting Number: 21-001-00)’ and other substances from the same read-across categorypresent low systemic toxicity upon repeated dose oral exposure for which absorption is higher than via the dermal route, so that repeated dose dermal toxicity is also expected to be minimal.
Finally, based on its physical state (solid) and low vapour pressure (< 1.33 x 10-8Pa at 20°C), the possibility of inhalation exposure will be extremely limited. In many cases the substance is used in industrial applications and transported and handled in liquid form (heated). If the substance is in powder form, sprayed or otherwise finely dispersed in the air, the use of respiratory protection (filter mask) is recommended at workplace.Thus,repeated inhalation exposure is not expected to pose an issue for human health.
Based on the above information, the substance does not qualify for repeated dose toxicity classification according to Directive 67/548/EC or Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.